Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Brain protein I3 pseudogene 1 (BRI3P1) is a human pseudogene, meaning it is a genomic DNA sequence similar to a known gene (in this case, BRI3) but is non-functional due to mutations or lack of regulatory elements[1][7]. Pseudogenes like BRI3P1 generally do not encode active proteins. While some pseudogenes have regulatory effects on their parent genes or participate in noncoding RNA processes, no specific biological or disease function has been attributed to BRI3P1. There are no known drugs, biomarkers, or therapeutic applications related to this pseudogene. It is not considered a therapeutic target and is primarily of interest for genomic annotation and basic research purposes[1][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain protein I3 pseudogene 1 (BRI3P1).